Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

No reported Cost of Revenue figures are available to summarize.

Cost of Revenue history

Currency unavailable · from the income statement

No Cost of Revenue data reported for this period type.

Cost of Revenue vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Cost of Revenue for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ORKAOruka Therapeutics, Inc.LTM Sep 2026$62.25M USD—-10.0%—
SYRESpyre Therapeutics, Inc.LTM Sep 2026$45.25M USD+0.0%—50.0%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$1.98M USD-86.0%-44.1%23.7%
ALMSAlumis Inc. Common StockLTM Jun 2026$871K USD+6.2%+140.9%11.8%
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$407K USD——0.1%
IMUXImmunic, Inc.LTM Mar 2026$33K USD-50.0%——
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024€0 EUR———
ANABAnaptysBio, Inc.LTM Mar 2026-$38.15M USD-122.7%-69.9%16.4%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-50.0%-27.1%16.4%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.